Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 11/20 | 0.43 |
| ▸ | MAOB | P27338 | 11/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 7/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12795168 | 0.89 | MAOA (0.49) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL26779027 | 0.84 | KDM4E (0.46) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL12748168 | 0.84 | MAOA (0.50) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL12748082 | 0.84 | MAOA (0.50) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL26779063 | 0.82 | KDM4E (0.43) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL12795344 | 0.80 | MAOA (0.50) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL13579134 | 0.80 | MAOA (0.51) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL11994244 | 0.80 | KDM4E (0.51) | MAOAMAOBKDM4ENPC1ALDH1A1 | |
| SCHEMBL26779081 | 0.79 | KDM4E (0.43) | KDM4ENPC1ALDH1A1MAPTRAB9A | |
| SCHEMBL12795166 | 0.79 | MAOA (0.50) | MAOAMAOBKDM4ENPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10442940-B2 | Radiation curable compositions for food packaging | AGFA NV (BE) | 2019-10-15 | — | — | US | disclosed |
| US-10316204-B2 | Radiation curable compositions for food packaging | AGFA NV (BE) | 2019-06-11 | — | — | US | disclosed |
| US-9550898-B2 | Radiation curable compositions for food packaging | AGFA GRAPHICS NV (BE) | 2017-01-24 | — | — | US | disclosed |
| US-9550898-B2 | Radiation curable compositions for food packaging | AGFA GRAPHICS NV (BE) | 2017-01-24 | — | — | US | disclosed |
| US-20160208117-A1 | RADIATION CURABLE COMPOSITIONS FOR FOOD PACKAGING | AGFA GRAPHICS NV (BE) | 2016-07-21 | — | — | US | disclosed |
| US-20160208117-A1 | RADIATION CURABLE COMPOSITIONS FOR FOOD PACKAGING | AGFA GRAPHICS NV (BE) | 2016-07-21 | — | — | US | disclosed |
| US-20160200923-A1 | RADIATION CURABLE COMPOSITIONS FOR FOOD PACKAGING | AGFA NV (BE) | 2016-07-14 | — | — | US | disclosed |
| US-20160200923-A1 | RADIATION CURABLE COMPOSITIONS FOR FOOD PACKAGING | AGFA NV (BE) | 2016-07-14 | — | — | US | disclosed |
| US-20160200924-A1 | RADIATION CURABLE COMPOSITIONS FOR FOOD PACKAGING | AGFA NV (BE) | 2016-07-14 | — | — | US | disclosed |
| US-20160200924-A1 | RADIATION CURABLE COMPOSITIONS FOR FOOD PACKAGING | AGFA NV (BE) | 2016-07-14 | — | — | US | disclosed |
| US-8389769-B2 | Polymerizable type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-03-05 | — | — | US | disclosed |
| US-8389769-B2 | Polymerizable type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-03-05 | — | — | US | disclosed |
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-17 | — | — | US | disclosed |
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | CCNH, CRKL, ERH | MAOA 2208/4885MAOB 2396/4885KDM4E 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.